Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 739

1.

STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection.

Ferenci P, Asselah T, Foster GR, Zeuzem S, Sarrazin C, Moreno C, Ouzan D, Maevskaya M, Calinas F, Morano LE, Crespo J, Dufour JF, Bourlière M, Agarwal K, Forton D, Schuchmann M, Zehnter E, Nishiguchi S, Omata M, Kukolj G, Datsenko Y, Garcia M, Scherer J, Quinson AM, Stern JO; on behalf of the STARTVerso1 study group.

J Hepatol. 2015 Jan 2. pii: S0168-8278(14)00953-2. doi: 10.1016/j.jhep.2014.12.024. [Epub ahead of print]

PMID:
25559324
[PubMed - as supplied by publisher]
2.

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis.

Dultz G, Piiper A, Zeuzem S, Kronenberger B, Waidmann O.

Aliment Pharmacol Ther. 2014 Dec 19. doi: 10.1111/apt.13061. [Epub ahead of print]

PMID:
25523381
[PubMed - as supplied by publisher]
3.

Aktuelle Empfehlung zur Therapie der chronischen Hepatitis C

Sarrazin C, Berg T, Buggisch P, Dollinger M, Hinrichsen H, Hüppe D, Manns M, Mauss S, Petersen J, Simon KG, van Thiel I, Wedemeyer H, Zeuzem S.

Z Gastroenterol. 2014 Oct;52(10):1185-97. German. No abstract available.

PMID:
25513400
[PubMed - in process]
4.

Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-naïve Patients with Chronic Hepatitis C and Advanced Liver Fibrosis/Cirrhosis.

Zeuzem S, Soriano V, Asselah T, Gane EJ, Bronowicki JP, Angus P, Lohse AW, Stickel F, Müllhaupt B, Roberts S, Schuchmann M, Manns M, Bourlière M, Buti M, Stern JO, Gallivan JP, Voss F, Sabo JP, Böcher W, Mensa FJ; on behalf of the SOUND-C2 study group.

Antimicrob Agents Chemother. 2014 Dec 15. pii: AAC.04383-14. [Epub ahead of print]

PMID:
25512403
[PubMed - as supplied by publisher]
5.

MicroRNA Profiling of Laser-Microdissected Hepatocellular Carcinoma Reveals an Oncogenic Phenotype of the Tumor Capsule.

Peveling-Oberhag J, Seiz A, Döring C, Hartmann S, Köberle V, Liese J, Zeuzem S, Hansmann ML, Piiper A.

Transl Oncol. 2014 Dec;7(6):672-80. doi: 10.1016/j.tranon.2014.09.003.

PMID:
25500075
[PubMed]
Free Article
6.

Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.

Watcharin W, Schmithals C, Pleli T, Köberle V, Korkusuz H, Hübner F, Waidmann O, Zeuzem S, Korf H, Terfort A, Gelperina S, Vogl TJ, Kreuter J, Piiper A.

J Control Release. 2014 Dec 10;199C:63-71. doi: 10.1016/j.jconrel.2014.11.023. [Epub ahead of print]

PMID:
25499552
[PubMed - as supplied by publisher]
7.

Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial.

Reddy KR, Zeuzem S, Zoulim F, Weiland O, Horban A, Stanciu C, Villamil FG, Andreone P, George J, Dammers E, Fu M, Kurland D, Lenz O, Ouwerkerk-Mahadevan S, Verbinnen T, Scott J, Jessner W.

Lancet Infect Dis. 2015 Jan;15(1):27-35. doi: 10.1016/S1473-3099(14)71002-3. Epub 2014 Dec 5.

PMID:
25482330
[PubMed - in process]
8.

Functional testing strategy for coding genetic variants of unclear significance in MLH1 in Lynch syndrome diagnosis.

Hinrichsen I, Schäfer D, Langer D, Köger N, Wittmann M, Aretz S, Steinke V, Holzapfel S, Trojan J, König R, Zeuzem S, Brieger A, Plotz G.

Carcinogenesis. 2014 Dec 4. pii: bgu239. [Epub ahead of print]

PMID:
25477341
[PubMed - as supplied by publisher]
9.

Aktuelle Empfehlung zur Therapie der chronischen Hepatitis C

Sarrazin C, Berg T, Buggisch P, Dollinger M, Hinrichsen H, Hüppe D, Manns M, Mauss S, Petersen J, Simon KG, van Thiel I, Wedemeyer H, Zeuzem S.

Z Gastroenterol. 2014 Oct;52(10):1185-97. German. No abstract available.

PMID:
25473687
[PubMed - in process]
10.

The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure.

Jalan R, Pavesi M, Saliba F, Amorós A, Fernandez J, Holland-Fischer P, Sawhney R, Mookerjee R, Caraceni P, Moreau R, Gines P, Durand F, Angeli P, Alessandria C, Laleman W, Trebicka J, Samuel D, Zeuzem S, Gustot T, Gerbes AL, Wendon J, Bernardi M, Arroyo V; CANONIC Study Investigators; EASL-CLIF Consortium.

J Hepatol. 2014 Nov 22. pii: S0168-8278(14)00856-3. doi: 10.1016/j.jhep.2014.11.012. [Epub ahead of print]

PMID:
25463539
[PubMed - as supplied by publisher]
11.

Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β-induction by efficient MAVS cleavage.

Welsch C, Haselow K, Gouttenoire J, Schneider M, Morikawa K, Martinez Y, Susser S, Sarrazin C, Zeuzem S, Antes I, Moradpour D, Lange CM.

J Hepatol. 2014 Nov 21. pii: S0168-8278(14)00853-8. doi: 10.1016/j.jhep.2014.11.009. [Epub ahead of print]

PMID:
25463536
[PubMed - as supplied by publisher]
12.

Intracellular accumulation of subviral HBsAg particles and diminished Nrf2 activation in HBV genotype G expressing cells lead to an increased ROI level.

Peiffer KH, Akhras S, Himmelsbach K, Hassemer M, Finkernagel M, Carra G, Nuebling M, Chudy M, Niekamp H, Glebe D, Sarrazin C, Zeuzem S, Hildt E.

J Hepatol. 2014 Nov 28. pii: S0168-8278(14)00877-0. doi: 10.1016/j.jhep.2014.11.028. [Epub ahead of print]

PMID:
25445396
[PubMed - as supplied by publisher]
13.

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors.

Welzel TM, Dultz G, Zeuzem S.

J Hepatol. 2014 Nov;61(1 Suppl):S98-S107. doi: 10.1016/j.jhep.2014.08.014. Epub 2014 Nov 3.

PMID:
25443350
[PubMed - in process]
Free Article
14.

Overcoming the roadblocks in hepatitis C virus infection.

Baumert TF, Zeuzem S.

J Hepatol. 2014 Nov;61(1 Suppl):S1-2. doi: 10.1016/j.jhep.2014.08.034. Epub 2014 Nov 3. No abstract available.

PMID:
25443338
[PubMed - in process]
Free Article
15.

Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.

Susser S, Herrmann E, Lange C, Hamdi N, Müller T, Berg T, Perner D, Zeuzem S, Sarrazin C.

PLoS One. 2014 Nov 13;9(11):e112592. doi: 10.1371/journal.pone.0112592. eCollection 2014.

PMID:
25393304
[PubMed - in process]
Free PMC Article
16.

Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general population.

van der Meer AJ, Wedemeyer H, Feld JJ, Dufour JF, Zeuzem S, Hansen BE, Janssen HL.

JAMA. 2014 Nov 12;312(18):1927-8. doi: 10.1001/jama.2014.12627. No abstract available.

PMID:
25387192
[PubMed - indexed for MEDLINE]
17.

Role of telaprevir plasma levels for predicting response to antiviral therapy in patients with hepatitis C virus genotype 1 infection.

Farnik H, Ferreirós N, Labocha S, Geisslinger G, Zeuzem S, Sarrazin C, Vermehren J.

Scand J Gastroenterol. 2014 Dec;49(12):1473-9. doi: 10.3109/00365521.2014.978363. Epub 2014 Nov 11.

PMID:
25384840
[PubMed - in process]
18.

Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies.

Manns MP, Fried MW, Zeuzem S, Jacobson IM, Forns X, Poordad F, Peeters M, Fu M, Lenz O, Ouwerkerk-Mahadevan S, Jessner W, Scott JA, Kalmeijer R, De La Rosa G, Sinha R, Beumont-Mauviel M.

J Viral Hepat. 2014 Nov 3. doi: 10.1111/jvh.12346. [Epub ahead of print]

PMID:
25363449
[PubMed - as supplied by publisher]
19.

Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in HCV but not HBV infection.

Grammatikos G, Ferreiros N, Bon D, Schwalm S, Dietz J, Berkowski C, Fitting D, Herrmann E, Zeuzem S, Sarrazin C, Pfeilschifter J.

Hepatology. 2014 Oct 28. doi: 10.1002/hep.27587. [Epub ahead of print]

PMID:
25348752
[PubMed - as supplied by publisher]
20.

Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study.

Berg T, Andreone P, Pol S, Roberts S, Younossi Z, Diago M, Lawitz EJ, Focaccia R, Foster GR, Horban A, Lonjon-Domanec I, DeMasi R, Picchio G, Luo D, De Meyer S, Zeuzem S.

Liver Int. 2015 Feb;35(2):448-54. doi: 10.1111/liv.12703. Epub 2014 Nov 11.

PMID:
25319731
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk